These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22919678)

  • 61. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.
    Glomski IJ; Piris-Gimenez A; Huerre M; Mock M; Goossens PL
    PLoS Pathog; 2007 Jun; 3(6):e76. PubMed ID: 17542645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of raxibacumab on immunogenicity of Anthrax Vaccine Adsorbed: a phase 4, open-label, parallel-group, randomised non-inferiority study.
    Skoura N; Wang-Jairaj J; Della Pasqua O; Chandrasekaran V; Billiard J; Yeakey A; Smith W; Steel H; Tan LK
    Lancet Infect Dis; 2020 Aug; 20(8):983-991. PubMed ID: 32333847
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Animal Models for the Pathogenesis, Treatment, and Prevention of Infection by Bacillus anthracis.
    Welkos S; Bozue J; Twenhafel N; Cote C
    Microbiol Spectr; 2015 Feb; 3(1):TBS-0001-2012. PubMed ID: 26104551
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A case report of inhalation anthrax acquired naturally.
    Azarkar Z; Bidaki MZ
    BMC Res Notes; 2016 Mar; 9():141. PubMed ID: 26939756
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis.
    Thomas RJ; Davies C; Nunez A; Hibbs S; Eastaugh L; Harding S; Jordan J; Barnes K; Oyston P; Eley S
    Front Cell Infect Microbiol; 2012; 2():101. PubMed ID: 22919690
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.
    Cote CK; Bozue J; Twenhafel N; Welkos SL
    J Med Microbiol; 2009 Jun; 58(Pt 6):816-825. PubMed ID: 19429760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.
    Klas SD; Petrie CR; Warwood SJ; Williams MS; Olds CL; Stenz JP; Cheff AM; Hinchcliffe M; Richardson C; Wimer S
    Vaccine; 2008 Oct; 26(43):5494-502. PubMed ID: 18703110
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
    Savransky V; Shearer JD; Gainey MR; Sanford DC; Sivko GS; Stark GV; Li N; Ionin B; Lacy MJ; Skiadopoulos MH
    Vaccine; 2017 Sep; 35(37):4952-4959. PubMed ID: 28774566
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice.
    Lv J; Zhang YY; Lu X; Zhang H; Wei L; Gao J; Hu B; Hu WW; Hu DZ; Jia N; Feng X
    Biologicals; 2017 Mar; 46():130-138. PubMed ID: 28215694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host.
    Weiner ZP; Glomski IJ
    Infect Immun; 2012 May; 80(5):1626-33. PubMed ID: 22354031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathology and pathogenesis of bioterrorism-related inhalational anthrax.
    Guarner J; Jernigan JA; Shieh WJ; Tatti K; Flannagan LM; Stephens DS; Popovic T; Ashford DA; Perkins BA; Zaki SR;
    Am J Pathol; 2003 Aug; 163(2):701-9. PubMed ID: 12875989
    [TBL] [Abstract][Full Text] [Related]  

  • 73. From the Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax.
    JAMA; 2002 Feb; 287(5):579. PubMed ID: 11838446
    [No Abstract]   [Full Text] [Related]  

  • 74. Nosocomial infection of Serratia marcescens may induce a protective effect in monkeys exposed to Bacillus anthracis.
    Leffel EK; Twenhafel NA; Whitehouse CA
    J Infect; 2008 Aug; 57(2):162-4. PubMed ID: 18538851
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
    Kachura MA; Hickle C; Kell SA; Sathe A; Calacsan C; Kiwan R; Hall B; Milley R; Ott G; Coffman RL; Kanzler H; Campbell JD
    J Immunol; 2016 Jan; 196(1):284-97. PubMed ID: 26608924
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.
    Booth JL; Duggan ES; Patel VI; Langer M; Wu W; Braun A; Coggeshall KM; Metcalf JP
    Microbes Infect; 2016 Oct; 18(10):615-626. PubMed ID: 27320392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhuman primate models of inhalational anthrax: Data supporting approval under animal rule.
    Kammanadiminti S; Comer J; Meister G; Carnelley T; Toth D; Kodihalli S
    PLoS One; 2023; 18(3):e0283164. PubMed ID: 36930692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contribution of toxins to the pathogenesis of inhalational anthrax.
    Tournier JN; Quesnel-Hellmann A; Cleret A; Vidal DR
    Cell Microbiol; 2007 Mar; 9(3):555-65. PubMed ID: 17223930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.